New Oral Heart Failure Drug Shows Promise in Early Clinical Trial Results
Medical Xpress1 min read35 words
An early clinical study shows that a new oral drug is safe and well tolerated in patients with chronic heart failure. The study, led by researchers at Karolinska Institutet, has been published in The Lancet.
Read the original at Medical Xpress
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.